Cargando…
Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy. We present a cas...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825832/ https://www.ncbi.nlm.nih.gov/pubmed/36153647 http://dx.doi.org/10.1002/ccd.30411 |
_version_ | 1784866708517814272 |
---|---|
author | Fanta, Lauren E. Ewer, Steven M. Gimelli, Giorgio Reilly, Nicole M. |
author_facet | Fanta, Lauren E. Ewer, Steven M. Gimelli, Giorgio Reilly, Nicole M. |
author_sort | Fanta, Lauren E. |
collection | PubMed |
description | Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy. We present a case of a 70‐year‐old man with cardiac light‐chain amyloidosis and LVOT obstruction successfully treated with alcohol septal ablation (ASA). Following the procedure, he reported significant improvement in his heart failure symptoms as well as improvement in LVOT gradient and SAM of the mitral valve. This case demonstrates that ASA is a technically feasible and effective procedure for relieving LVOT obstruction in cardiac amyloidosis and can be considered as a treatment option in patients whose symptoms are refractory to medical therapy. |
format | Online Article Text |
id | pubmed-9825832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98258322023-01-09 Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy Fanta, Lauren E. Ewer, Steven M. Gimelli, Giorgio Reilly, Nicole M. Catheter Cardiovasc Interv Valvular and Structural Heart Diseases Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy. We present a case of a 70‐year‐old man with cardiac light‐chain amyloidosis and LVOT obstruction successfully treated with alcohol septal ablation (ASA). Following the procedure, he reported significant improvement in his heart failure symptoms as well as improvement in LVOT gradient and SAM of the mitral valve. This case demonstrates that ASA is a technically feasible and effective procedure for relieving LVOT obstruction in cardiac amyloidosis and can be considered as a treatment option in patients whose symptoms are refractory to medical therapy. John Wiley and Sons Inc. 2022-09-24 2022-11-01 /pmc/articles/PMC9825832/ /pubmed/36153647 http://dx.doi.org/10.1002/ccd.30411 Text en © 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Valvular and Structural Heart Diseases Fanta, Lauren E. Ewer, Steven M. Gimelli, Giorgio Reilly, Nicole M. Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy |
title | Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy |
title_full | Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy |
title_fullStr | Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy |
title_full_unstemmed | Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy |
title_short | Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy |
title_sort | alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: new indication for an established therapy |
topic | Valvular and Structural Heart Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825832/ https://www.ncbi.nlm.nih.gov/pubmed/36153647 http://dx.doi.org/10.1002/ccd.30411 |
work_keys_str_mv | AT fantalaurene alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy AT ewerstevenm alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy AT gimelligiorgio alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy AT reillynicolem alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy |